サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1566925

医療機器としてのソフトウェア市場：展開タイプ別、用途別、エンドユーザー別：世界の機会分析と産業予測、2024年～2033年

Software as a Medical Device Market By Deployment Type , By Application By End User : Global Opportunity Analysis and Industry Forecast, 2024-2033

出版日
ページ情報
英文 233 Pages
納期
2～3営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
医療機器としてのソフトウェア市場：展開タイプ別、用途別、エンドユーザー別：世界の機会分析と産業予測、2024年～2033年
出版日: 2024年07月10日
発行: Allied Market Research
ページ情報: 英文 233 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

医療機器としての（SaMD）ソフトウェア市場

医療機器としての（SaMD）ソフトウェア市場は、2023年に1,950万米ドルと評価され、2024年から2033年にかけてCAGR 17.3%で成長し、2033年には9,620万米ドルに達すると予測されています。

医療機器としてのソフトウェア（SaMD）は、医療用に設計された専用ソフトウェアで、ハードウェアの医療機器を必要とせずに機能を実行できます。SaMDは、患者の健康データの管理、健康状態の診断、治療の推奨を支援します。このソフトウェアは、スマートフォンやタブレットなどの汎用コンピューティングプラットフォームで簡単にアクセスできるため、汎用性が高く、アクセスしやすいです。SaMDの主な特徴は、医療目的を独自に達成する可能性があることで、それによって現代のヘルスケアシステムの範囲と効率を加速させる。

遠隔医療と遠隔患者モニタリングの採用増加は、医療機器としての（SaMD）ソフトウェア市場の主な促進要因です。さらに、食品医薬品局や欧州連合などの複数の規制機関からの支援が、SaMDの需要を押し上げています。ヘルスケア提供者の支援を向上させるため、臨床意思決定支援システム（CDSS）の組み込みが市場の新たな動向となっています。CDSSの機能は、エビデンスに基づいた臨床判断に役立つため、診断精度が向上し、治療手順が最適化されます。

しかし、既存の医療記録やヘルスケアデータをSaMDに統合するには時間とコストがかかるため、医療機器としてのソフトウェア（SaMD）市場の開拓を妨げています。さらに、ソフトウェアの使用は米国食品医薬品局（FDA）による厳格な規制遵守の対象となるため、SaMD開発者にとって大きな課題となっています。FDAの規制要件には、市販前承認、厳格な品質チェック、市販後調査、サイバーセキュリティ要件、特定のソフトウェアの修正と更新が含まれます。これらの要件はすべて、SaMDの信頼性と有効性を保証し、重要な医療データや患者記録の漏洩を防ぐものです。

セグメントレビュー

医療機器としての（SaMD）ソフトウェア市場は、展開タイプ、アプリケーション、エンドユーザー、地域に区分されます。展開タイプに基づき、市場はクラウドベースとオンプレミスに二分されます。アプリケーションによって、スクリーニング＆診断、モニタリング＆アラート、慢性疾患管理、デジタル治療、その他に分けられます。エンドユーザー別では、病院・診療所、在宅ケア環境、その他に分類されます。地域別では、北米、欧州、アジア太平洋、LAMEAで分析されています。

主な調査結果

展開タイプ別では、クラウドベースのセグメントが医療機器としての（SaMD）ソフトウェア市場を独占しています。

アプリケーション別では、スクリーニング＆診断分野が高い市場シェアを占めています。

エンドユーザー別では、病院・診療所が高いシェアを占めています。

地域別では、北米が医療機器としての（SaMD）ソフトウェア市場で最も高い収益を上げています。

本レポートで可能なカスタマイズ（追加費用とスケジュールが必要です。）

  • 規制ガイドライン
  • クライアントの関心に応じた追加企業プロファイル
  • 国別または地域別の追加分析-市場規模と予測
  • 企業プロファイルの拡張リスト
  • 過去の市場データ
  • 主要プレーヤーの詳細（所在地、連絡先、サプライヤー／ベンダーネットワークなどを含む、エクセル形式）

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場情勢

  • 市場の定義と範囲
  • 主な調査結果
    • 主な投資機会
    • 主要成功戦略
  • ポーターのファイブフォース分析
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会

第4章 医療機器としてのソフトウェア（SAMD）市場：展開タイプ別

  • 市場概要
  • クラウドベース
  • オンプレミス

第5章 医療機器としてのソフトウェア（SAMD）市場：用途別

  • 市場概要
  • スクリーニングと診断
  • モニタリングとアラート
  • 慢性疾患管理
  • デジタル治療
  • その他

第6章 医療機器としてのソフトウェア（SAMD）市場：エンドユーザー別

  • 市場概要
  • 病院と診療所
  • 在宅医療
  • その他

第7章 医療機器としてのソフトウェア（SAMD）市場：地域別

  • 市場概要
  • 北米
    • 主な市場動向と機会
    • 米国：医療機器としてのソフトウェア（SaMD）市場
    • カナダ医療機器としてのソフトウェア（SaMD）市場
    • メキシコの医療機器としてのソフトウェア（SaMD）市場
  • 欧州
    • 主な市場動向と機会
    • ドイツの医療機器としてのソフトウェア（SaMD）市場
    • フランス医療機器としてのソフトウェア（SaMD）市場
    • 英国の医療機器としてのソフトウェア（SaMD）市場
    • イタリアの医療機器としてのソフトウェア（SaMD）市場
    • スペインの医療機器としてのソフトウェア（SaMD）市場
    • その他欧州の医療機器としてのソフトウェア（SaMD）市場
  • アジア太平洋
    • 主な市場動向と機会
    • 日本の医療機器としてのソフトウェア（SaMD）市場
    • 中国医療機器としてのソフトウェア（SaMD）市場
    • インド医療機器としてのソフトウェア（SaMD）市場
    • オーストラリア医療機器としてのソフトウェア（SaMD）市場
    • 韓国医療機器としてのソフトウェア（SaMD）市場
    • その他アジア太平洋の医療機器としてのソフトウェア（SaMD）市場
  • ラテンアメリカ・中東・アフリカ
    • 主な市場動向と機会
    • ブラジルの医療機器としてのソフトウェア（SaMD）市場
    • サウジアラビアの医療機器としてのソフトウェア（SaMD）市場
    • 南アフリカ：医療機器としてのソフトウェア（SaMD）市場
    • その他のラテンアメリカ・中東・アフリカの医療機器としてのソフトウェア（SaMD）市場

第8章 競合情勢

  • イントロダクション
  • 主要成功戦略
  • 主要10企業の製品マッピング
  • 競合ダッシュボード
  • 競合ヒートマップ
  • 主要企業のポジショニング（2023年）

第9章 企業プロファイル

  • MindMaze
  • Siemens
  • Biofourmis
  • BrightInsight, Inc.
  • 4S Information Systems Ltd,
  • Viz.ai, Inc.
  • F. Hoffmann-La Roche Ltd
  • Koninklijke Philips N.V.,
  • Orthogonal
  • Zuhlke Engineering AG
目次
Product Code: A323957

(SaMD) Software as a Medical Device Market

The (SaMD) software as a medical device market was valued at $19.5 million in 2023 and is projected to reach $96.2 million by 2033, growing at a CAGR of 17.3% from 2024 to 2033.

Software as a medical device (SaMD) is dedicated software designed for medical use through which functions are performed without the requirement of a hardware medical device. SaMD aids in managing patient health data, diagnosing health conditions, and recommending treatments. The software is highly versatile and accessible as it is easily accessible on general-purpose computing platforms such as smartphones and tablets. A key characteristic of SaMD is its potential to independently accomplish medical objectives, thereby accelerating the scope and efficiency of modern healthcare systems.

Increase in the adoption of telehealth and remote patient monitoring is a major driver of the (SaMD) software as a medical device market. In addition, support from several regulatory bodies such as the Food and Drug Administration and the European Union is boosting the demand for SaMD. To improve the healthcare providers' assistance, the incorporation of Clinical Decision Support Systems (CDSS) is an emerging trend in the market. The capabilities of CDSS help in making evidence-based clinical decisions, thereby enhancing diagnostic accuracy and optimizing treatment procedures.

However, the integration of existing medical records and healthcare data into SaMD is a time-consuming and costly process, hence hampering the development of the (SaMD) software as a medical device market. Furthermore, usage of the software is subject to rigorous regulatory compliance by the U.S. Food and Drug Administration (FDA), which presents significant challenges for the SaMD developers. The regulatory requirements of FDA include premarket approval, strict quality check, post-market surveillance, cybersecurity requirements, and specific software modifications & updates. All these requirements ensure the reliability and efficacy of SaMD, thus preventing compromise with critical health data and patient records.

Segment Review

The (SaMD) software as a medical device market is segmented into deployment type, application, end user, and region. On the basis of deployment type, the market is bifurcated into cloud based and on premise. Depending on application, it is divided into screening & diagnosis, monitoring & alerting, chronic disease management, digital therapeutics, and others. As per end user, it is classified into hospitals & clinics, home care settings, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of deployment type, the cloud-based segment dominates the (SaMD) software as a medical device market.

Depending on application, the screening & diagnosis segment accounts for a high market share.

As per end user, the hospitals & clinics segment acquires a high stake in the market.

Region wise, North America is the highest revenue generator in the (SaMD) software as a medical device market.

Competition Analysis

The major players operating in the global (SaMD) software as a medical device market include MindMaze , Siemens, Biofourmis, BrightInsight, Inc., 4S Information Systems Ltd, Viz.ai, Inc., F. Hoffmann-La Roche Ltd, Koninklijke Philips N.V., Orthogonal, and Zuhlke Engineering AG. These players have adopted various key developmental strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • Key player details (including location, contact details, supplier/vendor network etc. in excel format)

Key Market Segments

By Deployment Type

  • Cloud Based
  • On Premise

By Application

  • Screening and Diagnosis
  • Monitoring and Alerting
  • Chronic Disease Management
  • Digital Therapeutics
  • Others

By End User

  • Hospitals and Clinics
  • Home Care Settings
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players:

    • MindMaze
    • Siemens
    • Biofourmis
    • BrightInsight, Inc.
    • 4S Information Systems Ltd,
    • Viz.ai, Inc.
    • F. Hoffmann-La Roche Ltd
    • Koninklijke Philips N.V.,
    • Orthogonal
    • Zuhlke Engineering AG

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY DEPLOYMENT TYPE

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Deployment Type
  • 4.2. Cloud Based
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. On Premise
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country

CHAPTER 5: SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY APPLICATION

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By Application
  • 5.2. Screening And Diagnosis
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Monitoring And Alerting
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country
  • 5.4. Chronic Disease Management
    • 5.4.1. Key Market Trends, Growth Factors and Opportunities
    • 5.4.2. Market Size and Forecast, By Region
    • 5.4.3. Market Share Analysis, By Country
  • 5.5. Digital Therapeutics
    • 5.5.1. Key Market Trends, Growth Factors and Opportunities
    • 5.5.2. Market Size and Forecast, By Region
    • 5.5.3. Market Share Analysis, By Country
  • 5.6. Others
    • 5.6.1. Key Market Trends, Growth Factors and Opportunities
    • 5.6.2. Market Size and Forecast, By Region
    • 5.6.3. Market Share Analysis, By Country

CHAPTER 6: SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY END USER

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By End User
  • 6.2. Hospitals And Clinics
    • 6.2.1. Key Market Trends, Growth Factors and Opportunities
    • 6.2.2. Market Size and Forecast, By Region
    • 6.2.3. Market Share Analysis, By Country
  • 6.3. Home Care Settings
    • 6.3.1. Key Market Trends, Growth Factors and Opportunities
    • 6.3.2. Market Size and Forecast, By Region
    • 6.3.3. Market Share Analysis, By Country
  • 6.4. Others
    • 6.4.1. Key Market Trends, Growth Factors and Opportunities
    • 6.4.2. Market Size and Forecast, By Region
    • 6.4.3. Market Share Analysis, By Country

CHAPTER 7: SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY REGION

  • 7.1. Market Overview
    • 7.1.1 Market Size and Forecast, By Region
  • 7.2. North America
    • 7.2.1. Key Market Trends and Opportunities
    • 7.2.2. Market Size and Forecast, By Deployment Type
    • 7.2.3. Market Size and Forecast, By Application
    • 7.2.4. Market Size and Forecast, By End User
    • 7.2.5. Market Size and Forecast, By Country
    • 7.2.6. U.S. Software as a Medical Device (SaMD) Market
      • 7.2.6.1. Market Size and Forecast, By Deployment Type
      • 7.2.6.2. Market Size and Forecast, By Application
      • 7.2.6.3. Market Size and Forecast, By End User
    • 7.2.7. Canada Software as a Medical Device (SaMD) Market
      • 7.2.7.1. Market Size and Forecast, By Deployment Type
      • 7.2.7.2. Market Size and Forecast, By Application
      • 7.2.7.3. Market Size and Forecast, By End User
    • 7.2.8. Mexico Software as a Medical Device (SaMD) Market
      • 7.2.8.1. Market Size and Forecast, By Deployment Type
      • 7.2.8.2. Market Size and Forecast, By Application
      • 7.2.8.3. Market Size and Forecast, By End User
  • 7.3. Europe
    • 7.3.1. Key Market Trends and Opportunities
    • 7.3.2. Market Size and Forecast, By Deployment Type
    • 7.3.3. Market Size and Forecast, By Application
    • 7.3.4. Market Size and Forecast, By End User
    • 7.3.5. Market Size and Forecast, By Country
    • 7.3.6. Germany Software as a Medical Device (SaMD) Market
      • 7.3.6.1. Market Size and Forecast, By Deployment Type
      • 7.3.6.2. Market Size and Forecast, By Application
      • 7.3.6.3. Market Size and Forecast, By End User
    • 7.3.7. France Software as a Medical Device (SaMD) Market
      • 7.3.7.1. Market Size and Forecast, By Deployment Type
      • 7.3.7.2. Market Size and Forecast, By Application
      • 7.3.7.3. Market Size and Forecast, By End User
    • 7.3.8. UK Software as a Medical Device (SaMD) Market
      • 7.3.8.1. Market Size and Forecast, By Deployment Type
      • 7.3.8.2. Market Size and Forecast, By Application
      • 7.3.8.3. Market Size and Forecast, By End User
    • 7.3.9. Italy Software as a Medical Device (SaMD) Market
      • 7.3.9.1. Market Size and Forecast, By Deployment Type
      • 7.3.9.2. Market Size and Forecast, By Application
      • 7.3.9.3. Market Size and Forecast, By End User
    • 7.3.10. Spain Software as a Medical Device (SaMD) Market
      • 7.3.10.1. Market Size and Forecast, By Deployment Type
      • 7.3.10.2. Market Size and Forecast, By Application
      • 7.3.10.3. Market Size and Forecast, By End User
    • 7.3.11. Rest of Europe Software as a Medical Device (SaMD) Market
      • 7.3.11.1. Market Size and Forecast, By Deployment Type
      • 7.3.11.2. Market Size and Forecast, By Application
      • 7.3.11.3. Market Size and Forecast, By End User
  • 7.4. Asia-Pacific
    • 7.4.1. Key Market Trends and Opportunities
    • 7.4.2. Market Size and Forecast, By Deployment Type
    • 7.4.3. Market Size and Forecast, By Application
    • 7.4.4. Market Size and Forecast, By End User
    • 7.4.5. Market Size and Forecast, By Country
    • 7.4.6. Japan Software as a Medical Device (SaMD) Market
      • 7.4.6.1. Market Size and Forecast, By Deployment Type
      • 7.4.6.2. Market Size and Forecast, By Application
      • 7.4.6.3. Market Size and Forecast, By End User
    • 7.4.7. China Software as a Medical Device (SaMD) Market
      • 7.4.7.1. Market Size and Forecast, By Deployment Type
      • 7.4.7.2. Market Size and Forecast, By Application
      • 7.4.7.3. Market Size and Forecast, By End User
    • 7.4.8. India Software as a Medical Device (SaMD) Market
      • 7.4.8.1. Market Size and Forecast, By Deployment Type
      • 7.4.8.2. Market Size and Forecast, By Application
      • 7.4.8.3. Market Size and Forecast, By End User
    • 7.4.9. Australia Software as a Medical Device (SaMD) Market
      • 7.4.9.1. Market Size and Forecast, By Deployment Type
      • 7.4.9.2. Market Size and Forecast, By Application
      • 7.4.9.3. Market Size and Forecast, By End User
    • 7.4.10. South Korea Software as a Medical Device (SaMD) Market
      • 7.4.10.1. Market Size and Forecast, By Deployment Type
      • 7.4.10.2. Market Size and Forecast, By Application
      • 7.4.10.3. Market Size and Forecast, By End User
    • 7.4.11. Rest of Asia-Pacific Software as a Medical Device (SaMD) Market
      • 7.4.11.1. Market Size and Forecast, By Deployment Type
      • 7.4.11.2. Market Size and Forecast, By Application
      • 7.4.11.3. Market Size and Forecast, By End User
  • 7.5. LAMEA
    • 7.5.1. Key Market Trends and Opportunities
    • 7.5.2. Market Size and Forecast, By Deployment Type
    • 7.5.3. Market Size and Forecast, By Application
    • 7.5.4. Market Size and Forecast, By End User
    • 7.5.5. Market Size and Forecast, By Country
    • 7.5.6. Brazil Software as a Medical Device (SaMD) Market
      • 7.5.6.1. Market Size and Forecast, By Deployment Type
      • 7.5.6.2. Market Size and Forecast, By Application
      • 7.5.6.3. Market Size and Forecast, By End User
    • 7.5.7. Saudi Arabia Software as a Medical Device (SaMD) Market
      • 7.5.7.1. Market Size and Forecast, By Deployment Type
      • 7.5.7.2. Market Size and Forecast, By Application
      • 7.5.7.3. Market Size and Forecast, By End User
    • 7.5.8. South Africa Software as a Medical Device (SaMD) Market
      • 7.5.8.1. Market Size and Forecast, By Deployment Type
      • 7.5.8.2. Market Size and Forecast, By Application
      • 7.5.8.3. Market Size and Forecast, By End User
    • 7.5.9. Rest of LAMEA Software as a Medical Device (SaMD) Market
      • 7.5.9.1. Market Size and Forecast, By Deployment Type
      • 7.5.9.2. Market Size and Forecast, By Application
      • 7.5.9.3. Market Size and Forecast, By End User

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top Winning Strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Top Player Positioning, 2023

CHAPTER 9: COMPANY PROFILES

  • 9.1. MindMaze
    • 9.1.1. Company Overview
    • 9.1.2. Key Executives
    • 9.1.3. Company Snapshot
    • 9.1.4. Operating Business Segments
    • 9.1.5. Product Portfolio
    • 9.1.6. Business Performance
    • 9.1.7. Key Strategic Moves and Developments
  • 9.2. Siemens
    • 9.2.1. Company Overview
    • 9.2.2. Key Executives
    • 9.2.3. Company Snapshot
    • 9.2.4. Operating Business Segments
    • 9.2.5. Product Portfolio
    • 9.2.6. Business Performance
    • 9.2.7. Key Strategic Moves and Developments
  • 9.3. Biofourmis
    • 9.3.1. Company Overview
    • 9.3.2. Key Executives
    • 9.3.3. Company Snapshot
    • 9.3.4. Operating Business Segments
    • 9.3.5. Product Portfolio
    • 9.3.6. Business Performance
    • 9.3.7. Key Strategic Moves and Developments
  • 9.4. BrightInsight, Inc.
    • 9.4.1. Company Overview
    • 9.4.2. Key Executives
    • 9.4.3. Company Snapshot
    • 9.4.4. Operating Business Segments
    • 9.4.5. Product Portfolio
    • 9.4.6. Business Performance
    • 9.4.7. Key Strategic Moves and Developments
  • 9.5. 4S Information Systems Ltd,
    • 9.5.1. Company Overview
    • 9.5.2. Key Executives
    • 9.5.3. Company Snapshot
    • 9.5.4. Operating Business Segments
    • 9.5.5. Product Portfolio
    • 9.5.6. Business Performance
    • 9.5.7. Key Strategic Moves and Developments
  • 9.6. Viz.ai, Inc.
    • 9.6.1. Company Overview
    • 9.6.2. Key Executives
    • 9.6.3. Company Snapshot
    • 9.6.4. Operating Business Segments
    • 9.6.5. Product Portfolio
    • 9.6.6. Business Performance
    • 9.6.7. Key Strategic Moves and Developments
  • 9.7. F. Hoffmann-La Roche Ltd
    • 9.7.1. Company Overview
    • 9.7.2. Key Executives
    • 9.7.3. Company Snapshot
    • 9.7.4. Operating Business Segments
    • 9.7.5. Product Portfolio
    • 9.7.6. Business Performance
    • 9.7.7. Key Strategic Moves and Developments
  • 9.8. Koninklijke Philips N.V.,
    • 9.8.1. Company Overview
    • 9.8.2. Key Executives
    • 9.8.3. Company Snapshot
    • 9.8.4. Operating Business Segments
    • 9.8.5. Product Portfolio
    • 9.8.6. Business Performance
    • 9.8.7. Key Strategic Moves and Developments
  • 9.9. Orthogonal
    • 9.9.1. Company Overview
    • 9.9.2. Key Executives
    • 9.9.3. Company Snapshot
    • 9.9.4. Operating Business Segments
    • 9.9.5. Product Portfolio
    • 9.9.6. Business Performance
    • 9.9.7. Key Strategic Moves and Developments
  • 9.10. Zuhlke Engineering AG
    • 9.10.1. Company Overview
    • 9.10.2. Key Executives
    • 9.10.3. Company Snapshot
    • 9.10.4. Operating Business Segments
    • 9.10.5. Product Portfolio
    • 9.10.6. Business Performance
    • 9.10.7. Key Strategic Moves and Developments